skip to content
Home

Cambridge Immunology Network

 

CIN News Subscribe to News

Read more at: Natural killer cells meet invasive cells: what consequences on reproduction and cancer?

Natural killer cells meet invasive cells: what consequences on reproduction and cancer?

29 January 2020

Natural killer cells meet invasive cells: what consequences on reproduction and cancer? A new study published in Nature Communications by Francesco Colucci’s group (Department of Obstetrics and Gynaecology) in collaboration with Andrew Sharkey’s laboratory (Department of Pathology) identified subsets of human decidual...

Read more at: Cambridge iMAP team is shortlisted for the Big Beat Challenge

Cambridge iMAP team is shortlisted for the Big Beat Challenge

24 January 2020

570x380_imap.gif Cambridge iMAP team is shortlisted for the Big Beat Challenge The British Heart Foundation (BHF) has announced its shortlist of four research projects competing for a £30m reward as part of its Big Beat Challenge. International, multi-disciplinary groups of researchers were asked to identify and propose a...

Read more at: Menna Clatworthy receives an EFIS-IL Lecture Award

Menna Clatworthy receives an EFIS-IL Lecture Award

1 July 2019

Menna Clatworthy, a Group Leader in the University of Cambridge Molecular Immunity Unit based at the LMB, has won a prestigious EFIS-IL Lecture Award.

Read more at: Scientists at CITIID have success in receiving prestigious fellowships from the Wellcome Trust
Scientists at CITIID have success in receiving prestigious fellowships from the Wellcome Trust

Scientists at CITIID have success in receiving prestigious fellowships from the Wellcome Trust

10 June 2019

For more information got to: https://www.citiid.cam.ac.uk/wellcome-trust-fellowships/

Read more at: New prognostic test could enable personalised treatment of inflammatory bowel disease

New prognostic test could enable personalised treatment of inflammatory bowel disease

30 May 2019

Scientists at the University of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease in individuals, transforming treatments for patients and paving the way for a personalised approach.

Read more at: New prognostic test could enable personalised treatment of inflammatory bowel disease

New prognostic test could enable personalised treatment of inflammatory bowel disease

30 May 2019

Scientists at the University of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease in individuals, transforming treatments for patients and paving the way for a personalised approach.

Read more at: New prognostic test could enable personalised treatment of inflammatory bowel disease

New prognostic test could enable personalised treatment of inflammatory bowel disease

30 May 2019

Scientists at the University of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease in individuals, transforming treatments for patients and paving the way for a personalised approach.

Read more at: Marjory Stephenson Prize- Gordon Dougan FRS

Marjory Stephenson Prize- Gordon Dougan FRS

26 November 2018

Congratulations to Professor Gordon Dougan FRS, Department of Medicine, who has been awarded the 2019 Marjory Stephenson Prize

Read more at: Shedding light on uterine lymphocytes: the power of mouse models

Shedding light on uterine lymphocytes: the power of mouse models

1 November 2018

The uterus of humans and mice is home to many immune cells, including natural killer (NK) and other innate lymphoid cells (ILCs), which may play important roles in pregnancy. The uterine mucosa dynamically adapts to both the menstrual cycle and pregnancy and therefore it is particularly hard to study.

Read more at: ‘Latent’ Tuberculosis? It’s Not That Common, Experts Find- Lalita Ramakrishnan, Dept of Medicine, University of Cambridge
‘Latent’ Tuberculosis? It’s Not That Common, Experts Find- Lalita Ramakrishnan, Dept of Medicine, University of Cambridge

‘Latent’ Tuberculosis? It’s Not That Common, Experts Find- Lalita Ramakrishnan, Dept of Medicine, University of Cambridge

21 September 2018

Active infections kill 4,000 people a day worldwide, more than AIDS does. But the notion that a quarter of the global population harbors silent tuberculosis is “a fundamental misunderstanding.”

Contact us

Cambridge Immunology Network Coordinator

University of Cambridge Department of Medicine,
Jeffrey Cheah Biomedical Centre,
Cambridge Biomedical Campus, Puddicombe Way,
Cambridge, CB2 0AW

Contact: webmaster@immunology.cam.ac.uk

Site Privacy & Cookie Policies

 Follow us on Twitter

Watch our webinars

Sign up to our newsletter

We are a FOCIS centre of Excellence

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more

Study at Cambridge

About the University

Research at Cambridge